204 related articles for article (PubMed ID: 33163023)
1. Adherence to the MDR-TB intensive phase treatment protocol amongst individuals followed up at central and peripheral health care facilities in Uganda - a descriptive study.
Mukasa J; Kayongo E; Kawooya I; Lukoye D; Etwom A; Mugabe F; Tweya H; Izizinga R; Mijumbi-Deve R
Afr Health Sci; 2020 Jun; 20(2):625-632. PubMed ID: 33163023
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda.
Batte C; Namusobya MS; Kirabo R; Mukisa J; Adakun S; Katamba A
Afr Health Sci; 2021 Mar; 21(1):238-247. PubMed ID: 34394303
[TBL] [Abstract][Full Text] [Related]
3. Comparing adherence to MDR-TB treatment among patients on self-administered therapy and those on directly observed therapy: non-inferiority randomized controlled trial.
Wekesa C; Sekaggya-Wiltshire C; Muyanja SZ; Lume I; Nabaggala MS; Parkes-Ratanshi R; Akello SA
Trials; 2023 May; 24(1):326. PubMed ID: 37173761
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and factors associated with reported adverse-events among patients on multi-drug-resistant tuberculosis treatment in two referral hospitals in Uganda.
Ategyeka PM; Muhoozi M; Naturinda R; Kageni P; Namugenyi C; Kasolo A; Kisaka S; Kiwanuka N
BMC Infect Dis; 2023 Mar; 23(1):149. PubMed ID: 36899299
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
[TBL] [Abstract][Full Text] [Related]
6. Active contact tracing beyond the household in multidrug resistant tuberculosis in Vietnam: a cohort study.
Hoang TTT; Nguyen VN; Dinh NS; Thwaites G; Nguyen TA; van Doorn HR; Cobelens F; Wertheim HFL
BMC Public Health; 2019 Feb; 19(1):241. PubMed ID: 30819161
[TBL] [Abstract][Full Text] [Related]
7. Community-based directly observed therapy is effective and results in better treatment outcomes for patients with multi-drug resistant tuberculosis in Uganda.
Makabayi-Mugabe R; Musaazi J; Zawedde-Muyanja S; Kizito E; Fatta K; Namwanje-Kaweesi H; Turyahabwe S; Nkolo A
BMC Health Serv Res; 2023 Nov; 23(1):1248. PubMed ID: 37957610
[TBL] [Abstract][Full Text] [Related]
8. Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
Kasozi S; Kirirabwa NS; Kimuli D; Luwaga H; Kizito E; Turyahabwe S; Lukoye D; Byaruhanga R; Chen L; Suarez P
PLoS One; 2020; 15(12):e0244451. PubMed ID: 33373997
[TBL] [Abstract][Full Text] [Related]
9. Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
Cattamanchi A; Crowder R; Kityamuwesi A; Kiwanuka N; Lamunu M; Namale C; Tinka LK; Nakate AS; Ggita J; Turimumahoro P; Babirye D; Oyuku D; Berger C; Tucker A; Patel D; Sammann A; Turyahabwe S; Dowdy D; Katamba A
PLoS Med; 2021 May; 18(5):e1003628. PubMed ID: 33956802
[TBL] [Abstract][Full Text] [Related]
10. High rates of culture conversion and low loss to follow-up in MDR-TB patients managed at Regional Referral Hospitals in Uganda.
Martin MK; Paul OJ; Sara R; Hilary A; Frank M; Augustin MK; Stavia T; Christopher W; van Zanten TV; Gladys T
BMC Infect Dis; 2021 Oct; 21(1):1060. PubMed ID: 34641816
[TBL] [Abstract][Full Text] [Related]
11. Patient satisfaction with directly observed treatment and multidrug-resistant tuberculosis injection administration by lay health workers in rural Eswatini.
Peresu E; Heunis CJ; Kigozi GN; De Grave D
Afr J Prim Health Care Fam Med; 2020 May; 12(1):e1-e10. PubMed ID: 32501027
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Directly Observed Therapy (DOT) following tuberculosis regimen change in Addis Ababa, Ethiopia: a qualitative study.
Fiseha D; Demissie M
BMC Infect Dis; 2015 Sep; 15():405. PubMed ID: 26423277
[TBL] [Abstract][Full Text] [Related]
13. Home-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban Tanzania.
Mhimbira F; Hella J; Maroa T; Kisandu S; Chiryamkubi M; Said K; Mhalu G; Mkopi A; Mutayoba B; Reither K; Gagneux S; Fenner L
PLoS One; 2016; 11(8):e0161171. PubMed ID: 27513331
[TBL] [Abstract][Full Text] [Related]
14. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
[TBL] [Abstract][Full Text] [Related]
15. Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.
Bamrah S; Brostrom R; Dorina F; Setik L; Song R; Kawamura LM; Heetderks A; Mase S
Int J Tuberc Lung Dis; 2014 Aug; 18(8):912-8. PubMed ID: 25199004
[TBL] [Abstract][Full Text] [Related]
16. Yield of systematic household contact investigation for tuberculosis in a high-burden metropolitan district of South Africa.
Kigozi NG; Heunis JC; Engelbrecht MC
BMC Public Health; 2019 Jul; 19(1):867. PubMed ID: 31269950
[TBL] [Abstract][Full Text] [Related]
17. Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications.
Ali MH; Alrasheedy AA; Kibuule D; Godman B; Hassali MA; Ali HMH
Expert Rev Anti Infect Ther; 2019 Nov; 17(11):927-937. PubMed ID: 31689134
[No Abstract] [Full Text] [Related]
18. "Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.
Horter S; Stringer B; Reynolds L; Shoaib M; Kasozi S; Casas EC; Verputten M; du Cros P
BMC Health Serv Res; 2014 Feb; 14():81. PubMed ID: 24559177
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis screening in household contacts of pulmonary tuberculosis patients in an urban setting.
Velayutham B; Jayabal L; Watson B; Jagadeesan S; Angamuthu D; Rebecca P; Devaleenal B; Nair D; Tripathy S; Selvaraju S
PLoS One; 2020; 15(10):e0240594. PubMed ID: 33057399
[TBL] [Abstract][Full Text] [Related]
20. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.
Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas AN; Kumar AMV; Parmar M
Indian J Tuberc; 2018 Jan; 65(1):41-47. PubMed ID: 29332647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
